On the other hand, the survival analysis of GC patients from TCGA cohort showed that among the 5 UBE2C pseudogenes, only UBE2CP3’s expression was significantly related to the prognosis (OVS + DFS) of GC patients (Fig. 1D). The gene discussed is UBE2CP3; the disease is gastric cancer.